Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.44 |
| ▸ | NPY1R | P25929 | 6/20 | 0.44 |
| ▸ | NPY2R | P49146 | 4/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.40 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
| ▸ | OTC | P00480 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27086265 | 1.00 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL8526706 | 1.00 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL27086281 | 1.00 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL31688043 | 0.96 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL29695594 | 0.95 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL30716491 | 0.92 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL30898573 | 0.92 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RDPP7 | |
| SCHEMBL29816322 | 0.92 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RPDCD1LG2 | |
| SCHEMBL29850992 | 0.91 | PDCD1LG2 (0.49) | NPY4RNPY1RNPY2RNPY5RPDCD1LG2 | |
| SCHEMBL30531637 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2026-02-10 | — | — | US | claimed |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2025-09-09 | — | — | US | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| CN-118979012-A | Thawing liquid for ovum or embryo and preparation method and thawing method thereof | 上海北里永幸医疗器械有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-116836236-A | FGL1 affinity peptide and application thereof | 郑州大学 | 2023-10-03 | — | — | CN | claimed |
| US-20230084521-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2023-03-16 | — | — | US | claimed |
| CN-111793110-B | Application of DMSO-free cryopreservation liquid in stem cell cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-11-11 | — | — | CN | claimed |
| CN-111789100-B | Application of DMSO-free cryopreservation solution in cryopreservation of oocytes or embryos | 北京大学第三医院 | 2022-09-06 | — | — | CN | claimed |
| CN-111789099-B | Application of cryopreservation liquid containing peptide compounds in cryopreservation of oocytes or embryos | 北京大学第三医院 | 2022-09-06 | — | — | CN | claimed |
| CN-111789102-B | Application of thawing solution in thawing frozen and preserved oocyte or embryo | 北京大学第三医院 | 2022-07-12 | — | — | CN | claimed |
| US-20220192180-A1 | THAWING FLUID, PREPARATION METHOD THEREFOR AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-23 | — | — | US | claimed |
| US-20220167610-A1 | DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-02 | — | — | US | claimed |
| CN-111793108-B | Application of cryopreservation liquid containing peptide compounds in organ and tissue cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-05-27 | — | — | CN | claimed |
| CN-111793109-B | Peptide compound and cryopreservation liquid containing same | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | claimed |
| CN-111789103-B | Thawing solution for cryopreservation and thawing method | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | claimed |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2022-05-12 | — | — | US | claimed |
| CN-111793107-B | DMSO-free cryopreservation liquid and preparation method thereof | 中国科学院化学研究所 | 2022-04-12 | — | — | CN | claimed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | claimed |
| US-20220048988-A1 | CELLS EXPRESSING ANTIBODIES TARGETING HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USING THE SAME | CHILDREN'S NATIONAL MEDICAL CENTER | 2022-02-17 | — | — | US | claimed |
| WO-2026107381-A1 | DNA POLYMERASE THETA INHIBITORS, COMPOSITIONS THEREOF, COMPOSITIONS FURTHER COMPRISING A DNA DEPENDENT PROTEIN KINASE, AND USES OF BOTH IN GENE EDITING FIELD | JUNO THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-108350035-B | Cyclic polypeptides, methods for obtaining them and their use in therapy | 埃克斯欧力提斯药物公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-4039710-B1 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI SA (FR) | 2026-03-25 | — | — | EP | disclosed |
| EP-4702987-A1 | COMBINED USE OF BISPECIFIC ANTIBODY BINDING TO ACTIVATED COAGULATION FACTOR IX AND COAGULATION FACTOR X WITH BLOOD COAGULATION FACTOR X FOR TREATING SUBJECT WITH HEMOPHILIA A | Public University Corporation Nara Medical University (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2026-02-10 | — | — | US | disclosed |
| US-12453345-B2 | Serum-free cryopreservation solution and preparation method and application thereof | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2025-10-28 | — | — | US | disclosed |
| US-20250312361-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | EPALEX CORP (US) | 2025-10-09 | — | — | US | disclosed |
| US-20250312475-A1 | BIVALENT, BISPECIFIC BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION | SANOFI (FR) | 2025-10-09 | — | — | US | disclosed |
| EP-4622672-A1 | AMYLIN ANALOGUES | IP2IPO Innovations Limited (GB) | 2025-10-01 | — | — | EP | disclosed |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2025-09-09 | — | — | US | disclosed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250154687-A1 | ANTIBODY LIBRARIES | ADIMAB LLC (US) | 2025-05-15 | — | — | US | disclosed |
| EP-4536676-A2 | METHODS FOR PURIFICATION OF MULTI-SPECIFIC ANTIBODIES | Sanofi (FR) | 2025-04-16 | — | — | EP | disclosed |
| EP-4219805-B1 | ANTIBODY LIBRARIES | ADIMAB LLC (US) | 2025-02-26 | — | — | EP | disclosed |
| CN-119343359-A | Method for purifying multispecific antibodies | 赛诺菲 | 2025-01-21 | — | — | CN | disclosed |
| CN-119291194-A | Method for quantifying a polypeptide | 建新公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-110256569-B | Dual variable region antibody-like binding proteins with exchange binding region orientation | 赛诺菲 | 2025-01-07 | — | — | CN | disclosed |
| CN-118979012-A | Thawing liquid for ovum or embryo and preparation method and thawing method thereof | 上海北里永幸医疗器械有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-118955736-A | FVIIl-apoptin recombinant protein for targeted specificity induction of apoptosis of solid tumor cells, and preparation method and application thereof | 沈阳金石生物制药有限公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20240315296-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ CHEILJEDANG CORPORATION (KR) | 2024-09-26 | — | — | US | disclosed |
| CN-111801580-B | Method for quantifying a polypeptide | 建新公司 | 2024-08-23 | — | — | CN | disclosed |
| US-20240279362-A1 | TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS | SANOFI (FR) | 2024-08-22 | — | — | US | disclosed |
| CN-118406148-A | Antibodies to MADCAM | 辉瑞大药厂 | 2024-07-30 | — | — | CN | disclosed |
| CN-110753704-B | Bispecific antibodies to factor IX and factor X | 科马布有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-113453757-B | FIXaxFX bispecific antibodies with common light chain | 科马布有限公司 | 2024-06-28 | — | — | CN | disclosed |
| US-12018403-B2 | Antibody libraries | ADIMAB, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| WO-2024110763-A1 | AMYLIN ANALOGUES | IP2IPO INNOVATIONS LIMITED (GB) | 2024-05-30 | — | — | WO | disclosed |
| EP-4364582-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ Cheiljedang Corporation (KR) | 2024-05-08 | — | — | EP | disclosed |
| US-11976135-B2 | FIXaxFX bispecific antibody with common light chain | KYMAB LIMITED (GB) | 2024-05-07 | — | — | US | disclosed |
| US-11965030-B2 | Multispecific binding proteins with mutant fab domains | SANOFI (FR) | 2024-04-23 | — | — | US | disclosed |
| US-20240117022-A1 | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER | GANYMED PHARMACEUTICALS GMBH (DE) | 2024-04-11 | — | — | US | disclosed |
| CN-109476732-B | Trispecific and/or trivalent binding proteins | 赛诺菲 | 2024-03-22 | — | — | CN | disclosed |
| US-11932704-B2 | Trispecific and/or trivalent binding proteins | SANOFI (FR) | 2024-03-19 | — | — | US | disclosed |
| CN-117659184-A | Polyclonal antibody of Lawsonia intracellularis LI0004 protein, and preparation method and application thereof | 武汉轻工大学 | 2024-03-08 | — | — | CN | disclosed |
| CN-111032694-B | Antibodies to MADCAM | 辉瑞大药厂 | 2024-03-08 | — | — | CN | disclosed |
| US-11919969-B2 | Bispecific antibodies for factor IX and factor X | KYMAB LIMITED (GB) | 2024-03-05 | — | — | US | disclosed |
| CN-117604067-A | Novel coronavirus detection method, detection card, detection kit and protective mask | 张玥 | 2024-02-27 | — | — | CN | disclosed |
| US-20240018201-A1 | METHODS FOR PURIFICATION OF MULTI-SPECIFIC ANTIBODIES | SANOFI (FR) | 2024-01-18 | — | — | US | disclosed |
| CN-117264973-A | Construction and application of lactobacillus surface protein overexpression system | 宁波大学 | 2023-12-22 | — | — | CN | disclosed |
| WO-2023237690-A2 | METHODS FOR PURIFICATION OF MULTI-SPECIFIC ANTIBODIES | SANOFI (FR) | 2023-12-14 | — | — | WO | disclosed |
| EP-4288062-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | Epalex Corporation (US) | 2023-12-13 | — | — | EP | disclosed |
| US-20230391888-A1 | PSEUDOFAB-BASED MULTISPECIFIC BINDING PROTEINS | SANOFI (FR) | 2023-12-07 | — | — | US | disclosed |
| WO-2023221690-A1 | DETECTION METHOD, DETECTION CARD AND DETECTION KIT FOR SARS-COV-2, AND PROTECTIVE MASK | 张玥 | 2023-11-23 | — | — | WO | disclosed |
| CN-117089572-A | Low off-target base editor and construction thereof | 中国科学院天津工业生物技术研究所 | 2023-11-21 | — | — | CN | disclosed |
| CN-117069855-A | Trispecific and/or trivalent binding proteins for the prevention or treatment of HIV infection | 赛诺菲 | 2023-11-17 | — | — | CN | disclosed |
| US-11802156-B2 | Antibodies to MAdCAM | PFIZER INC. (US) | 2023-10-31 | — | — | US | disclosed |
| EP-4257193-A2 | TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS | Sanofi (FR) | 2023-10-11 | — | — | EP | disclosed |
| US-11779651-B2 | Bivalent, bispecific binding proteins for prevention or treatment of HIV infection | SANOFI (FR) | 2023-10-10 | — | — | US | disclosed |
| CN-116836236-A | FGL1 affinity peptide and application thereof | 郑州大学 | 2023-10-03 | — | — | CN | disclosed |
| CN-116789841-A | Trispecific and/or trivalent binding proteins for the prevention or treatment of HIV infection | 赛诺菲 | 2023-09-22 | — | — | CN | disclosed |
| EP-4242236-A2 | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER | Astellas Pharma Inc. (JP) | 2023-09-13 | — | — | EP | disclosed |
| US-11754573-B2 | Methods for the quantitation of polypeptides | GENZYME CORPORATION (US) | 2023-09-12 | — | — | US | disclosed |
| US-20230277567-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2023-09-07 | — | — | US | disclosed |
| CN-116675776-A | Trispecific and/or trivalent binding proteins for the prevention or treatment of HIV infection | 赛诺菲 | 2023-09-01 | — | — | CN | disclosed |
| CN-115806594-B | Recombinant antigen protein for detecting African swine fever virus, preparation method, detection kit and application thereof | 江苏农牧科技职业学院 | 2023-08-29 | — | — | CN | disclosed |
| US-11739139-B2 | Monoclonal antibodies against Claudin-18 for treatment of cancer | ASTELLAS PHARMA INC. (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11739160-B2 | PseudoFab-based multispecific binding proteins | SANOFI (FR) | 2023-08-29 | — | — | US | disclosed |
| EP-3443006-B1 | TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS | SANOFI SA (FR) | 2023-08-02 | — | — | EP | disclosed |
| EP-4219805-A1 | ANTIBODY LIBRARIES | Adimab, LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11628178-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2023-04-18 | — | — | US | disclosed |
| CN-110732018-B | Preparation method of tuna meat ACE inhibitory peptide chewable tablets | 浙江海洋大学 | 2023-04-07 | — | — | CN | disclosed |
| CN-115806594-A | Recombinant antigen protein for detecting African swine fever virus, preparation method, detection kit and application thereof | 江苏农牧科技职业学院 | 2023-03-17 | — | — | CN | disclosed |
| US-20230084521-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2023-03-16 | — | — | US | disclosed |
| CN-109311966-B | Trispecific and/or trivalent binding proteins for use in the prevention or treatment of HIV infection | 赛诺菲 | 2023-03-10 | — | — | CN | disclosed |
| EP-3401334-B1 | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER | ASTELLAS PHARMA INC (JP) | 2023-02-15 | — | — | EP | disclosed |
| WO-2023277549-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | 씨제이제일제당 (주) | 2023-01-05 | — | — | WO | disclosed |
| EP-4112645-A1 | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER | Astellas Pharma Inc. (JP) | 2023-01-04 | — | — | EP | disclosed |
| EP-3741883-B1 | ANTIBODY LIBRARIES | ADIMAB LLC (US) | 2022-12-14 | — | — | EP | disclosed |
| CN-111793111-B | Application of cryopreservation liquid containing peptide compounds in stem cell cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-11-29 | — | — | CN | disclosed |
| CN-113383767-B | Application of frozen stock solution in stem cell freezing | 北京大学第三医院（北京大学第三临床医学院） | 2022-11-22 | — | — | CN | disclosed |
| CN-111793110-B | Application of DMSO-free cryopreservation liquid in stem cell cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-11-11 | — | — | CN | disclosed |
| CN-115044652-A | Nucleic acid detection kit based on CRISPR/Cas12a system and up-conversion luminescent particle immunochromatography and application | 中国人民解放军军事科学院军事医学研究院 | 2022-09-13 | — | — | CN | disclosed |
| CN-111789100-B | Application of DMSO-free cryopreservation solution in cryopreservation of oocytes or embryos | 北京大学第三医院 | 2022-09-06 | — | — | CN | disclosed |
| CN-111789099-B | Application of cryopreservation liquid containing peptide compounds in cryopreservation of oocytes or embryos | 北京大学第三医院 | 2022-09-06 | — | — | CN | disclosed |
| US-20220265686-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-08-25 | — | — | US | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| WO-2022169520-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | EPALEX CORPORATION (US) | 2022-08-11 | — | — | WO | disclosed |
| EP-4039710-A2 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI (FR) | 2022-08-10 | — | — | EP | disclosed |
| CN-114885609-A | pseudo-Fab based multispecific binding proteins | 赛诺菲 | 2022-08-09 | — | — | CN | disclosed |
| US-20220226495-A1 | BIVALENT, BISPECIFIC BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION | SANOFI (FR) | 2022-07-21 | — | — | US | disclosed |
| CN-111789102-B | Application of thawing solution in thawing frozen and preserved oocyte or embryo | 北京大学第三医院 | 2022-07-12 | — | — | CN | disclosed |
| US-20220192179-A1 | BIOMIMETIC ICE-INHIBITING MATERIAL AND CRYOPRESERVATION SOLUTION COMPRISING SAME | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-23 | — | — | US | disclosed |
| US-20220192180-A1 | THAWING FLUID, PREPARATION METHOD THEREFOR AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-23 | — | — | US | disclosed |
| EP-4015538-A1 | FIXAXFX BISPECIFIC ANTIBODY WITH COMMON LIGHT CHAIN | Kymab Limited (GB) | 2022-06-22 | — | — | EP | disclosed |
| US-11359223-B2 | Expression sequences | LONZA LTD (CH) | 2022-06-14 | — | — | US | disclosed |
| US-20220167610-A1 | DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-02 | — | — | US | disclosed |
| CN-111793108-B | Application of cryopreservation liquid containing peptide compounds in organ and tissue cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-05-27 | — | — | CN | disclosed |
| CN-111793109-B | Peptide compound and cryopreservation liquid containing same | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | disclosed |
| CN-111789103-B | Thawing solution for cryopreservation and thawing method | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | disclosed |
| CN-114478789-A | anti-PD-L1 and OX40 bispecific antibodies and uses thereof | 安徽安科生物工程（集团）股份有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2022-05-12 | — | — | US | disclosed |
| US-20220119521-A1 | Antibodies to MAdCAM | PFIZER INC. | 2022-04-21 | — | — | US | disclosed |
| US-20220119553-A1 | TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS | SANOFI (FR) | 2022-04-21 | — | — | US | disclosed |
| CN-111793107-B | DMSO-free cryopreservation liquid and preparation method thereof | 中国科学院化学研究所 | 2022-04-12 | — | — | CN | disclosed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | disclosed |
| CN-114230668-A | anti-CD 3 antibodies, anti-CD 123 antibodies, and bispecific antibodies that specifically bind to CD3 and/or CD123 | 赛诺菲 | 2022-03-25 | — | — | CN | disclosed |
| CN-114230667-A | anti-CD 3 antibodies, anti-CD 123 antibodies, and bispecific antibodies that specifically bind to CD3 and/or CD123 | 赛诺菲 | 2022-03-25 | — | — | CN | disclosed |
| CN-111790327-B | Molecular design method of ice control material | 中国科学院化学研究所 | 2022-03-25 | — | — | CN | disclosed |
| US-20220048988-A1 | CELLS EXPRESSING ANTIBODIES TARGETING HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USING THE SAME | CHILDREN'S NATIONAL MEDICAL CENTER | 2022-02-17 | — | — | US | disclosed |
| EP-3656793-B1 | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER | ASTELLAS PHARMA INC (JP) | 2022-02-02 | — | — | EP | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
| US-9944925-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. | 2018-04-17 | — | — | US | disclosed |
| US-20160186168-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2016-06-30 | — | — | US | disclosed |
| EP-0885899-A1 | Method for obtaining peptide fragments by use of fluorinated organic acids | SEIKO INSTRUMENTS INC. (JP) | 1998-12-23 | — | — | EP | disclosed |
| US-4631270-A | THIOMETHYLENE REPLACEMENTS | RESEARCH CORPORATION (US) | 1986-12-23 | — | — | US | disclosed |
| US-4631270-A | THIOMETHYLENE REPLACEMENTS | RESEARCH CORPORATION (US) | 1986-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PCMT1, ARGLU1, TTR | NPY4R 3235/4885NPY1R 2711/4885NPY2R 3297/4885 |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | BCL2L1, BCL2, BCL2L11 | NPY4R 4591/4885NPY1R 4003/4885NPY2R 3929/4885 |
| US-11628178-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | NPY4R 879/4885NPY1R 2530/4885NPY2R 1464/4885 |
| US-20250154687-A1 | ANTIBODY LIBRARIES | FCGR3B, IGLV6-57, IGSF11 | NPY4R 3512/4885NPY1R 4049/4885NPY2R 4184/4885 |
| US-20250312361-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | FOS, FOSB, PFAS | NPY4R 879/4885NPY1R 2530/4885NPY2R 1464/4885 |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | BCL2, BCL2L1, BCL2L2 | NPY4R 4809/4885NPY1R 4266/4885NPY2R 4349/4885 |
| US-12453345-B2 | Serum-free cryopreservation solution and preparation method and application thereof | BCL2L1, BCL2, BCL2L11 | NPY4R 4591/4885NPY1R 4003/4885NPY2R 3929/4885 |
| US-12018403-B2 | Antibody libraries | FCGR3B, IGLV6-57, IGSF11 | NPY4R 3512/4885NPY1R 4049/4885NPY2R 4184/4885 |
| US-20230277567-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | FOS, FOSB, PFAS | NPY4R 879/4885NPY1R 2530/4885NPY2R 1464/4885 |
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | NPY4R 879/4885NPY1R 2530/4885NPY2R 1464/4885 |
| US-20220192179-A1 | BIOMIMETIC ICE-INHIBITING MATERIAL AND CRYOPRESERVATION SOLUTION COMPRISING SAME | IGFBP1, IGFBP2, BCL2L1 | NPY4R 4725/4885NPY1R 4515/4885NPY2R 4675/4885 |
| US-20220265686-A1 | FOSPROPOFOL METHODS AND COMPOSITIONS | FOS, FOSB, PFAS | NPY4R 879/4885NPY1R 2530/4885NPY2R 1464/4885 |
| US-20220167610-A1 | DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF | BCL2, BCL2L1, BCL2L2 | NPY4R 4809/4885NPY1R 4266/4885NPY2R 4349/4885 |
| US-20250312475-A1 | BIVALENT, BISPECIFIC BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION | CD4, HAVCR2, TIMCC | NPY4R 4597/4885NPY1R 4555/4885NPY2R 4485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.